Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)

This study has been completed.
Information provided by:
PharmaNeuroBoost N.V. Identifier:
First received: May 2, 2008
Last updated: April 29, 2011
Last verified: April 2011